IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

March 20th - Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

CME Congresses .

March 20th Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

March 4th- Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

CME Congresses .

March 4th – Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Feb 19th - Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

CME Congresses .

Feb 19th – Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Feb 9th - Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

CME Congresses .

Feb 9th – Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study

CME Congresses .

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study

January 19th 2025- Dr. Rohtesh Mehta- Haploidentical vs HLA-Matched Sibling Donor HCT with PTCy Prophylaxis: HLA Factors and Donor Age Considerations

CME Congresses .

January 19th 2025- Dr. Rohtesh Mehta- Haploidentical vs HLA-Matched Sibling Donor HCT with PTCy Prophylaxis: HLA Factors and Donor Age Considerations

January 15th 2025- Dr. William Wesson- Optimizing the Post-CAR T Monitoring Period in Recipients of Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel

CME Congresses .

January 15th 2025- Dr. William Wesson- Optimizing the Post-CAR T Monitoring Period in Recipients of Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel

January 5th 2025- Dr. Irina Amitai- Germ Line ERG Haploinsufficiency Defines a New Syndrome with Cytopenia and Hematological Malignancy Predisposition

CME Congresses .

Dr. Irina Amitai- Germ Line ERG Haploinsufficiency Defines a New Syndrome with Cytopenia and Hematological Malignancy Predisposition

December 31st 2024- Dr. Eduardo Rego- Clinical Networking Results in Continuous Improvement of the Outcome of Patients with Acute Promyelocytic Leukemia

CME Congresses .

Dr. Eduardo Rego- Clinical Networking Results in Continuous Improvement of the Outcome of Patients with Acute Promyelocytic Leukemia

December 23rd 2024- Dr. Omran Saifi- Outcomes of Patients with R/R B-Cell NHL and Limited (<5 sites) pre-CAR T Disease Bridged With or Without Radiotherapy

CME Congresses .

Dr. Omran Saifi- Outcomes of Patients with R/R B-Cell NHL and Limited (<5 sites) pre-CAR T Disease Bridged With or Without Radiotherapy